ConcertAI Acquires CancerLinQ

Read More

ConcertAI Announces Agreement with Leading Cancer Center

Read More

ConcertAI & Caris Life Sciences Expand Partnership

Learn More

ConcertAI & PathAI Partner Creating First-in-Class Histopathology and Curated Clinical RWD Product

Read More

ConcertAI and Caris Life Sciences Form Partnership Creating Industry’s Largest Molecular Oncology Research Biopharma Platform

Read More

Bristol Myers Squibb and ConcertAI Advance Novel Oncology Accelerated Digital Clinical Trial Solution

Learn More

QCCA and ConcertAI Partner on Novel Digital Clinical Trial Solutions

Learn More

ConcertAI Expands Partnership with Janssen Pharmaceuticals

Learn More

FDA Collaboration to Advance Use of RWE

Learn More

Erace

Promoting Cancer Health Equity

Learn More

Commercial Solutions to Increase Patient Adherence

Learn More

 

Making Equity and Trial Diversity Real

a Blog by Jeff Elton, CEO

Independent, Scalable and Specialized

The Industry’s Largest U.S. Oncology RWD

See Our Data
 
0+

EMR Systems

0+

AI Models

0+

Medical Oncologists

0+

Provider Cancer Clinics

Frequent

Data Refreshes

The ConcertAI Podcast is now live! Listen on your preferred platform or click the link below.

Click to listen now!

See All Events
Events

RSNA 2023

November 26, 2023

TeraRecon, a ConcertAI Company, will be attending this year’s Radiological Society of North America (RSNA) conference! Our goal is to connect with leading experts, share our cutting-edge imaging technologies, and stay updated with the latest trends in radiology. We’re excited about the opportunities this conference provides for networking, partnerships, and insights into the evolving role of AI in radiology.

Visit TeraRecon
Events

65th ASH Annual Meeting and Exposition

December 9, 2023

As a leader in healthcare technology, we recognize the importance of staying up-to-date with the latest developments in classical and malignant hematology. The ASH Annual Meeting and Exposition is the premier event for hematology experts from around the world, and we are thrilled to be part of this comprehensive event.

We can’t wait to join the world’s leading hematology experts at the 65th ASH Annual Meeting and Exposition in San Diego. Mark your calendars now and we hope to see you there!

Learn More
Events

SABCS 2023

December 5, 2023

ConcertAI is heading to SABCS 2023, a global symposium that’s at the forefront of breast cancer research and care. We look forward to immersing ourselves in expert lectures, presentations, and discussions on cutting-edge cancer science. Joining 9,500 attendees from over 100 countries, we’re ready to drive the future of healthcare with our AI-powered insights.

Click the link to set up a meeting with us in advance. Together, we can advance cancer care.

Meet with Us
Clinical Development

For Improved Patient Outcomes in Oncology

Our experienced team of scientists work with our data and AI technologies to accelerate trial data analysis and to help you implement novel data and analytics techniques for RCTs, pragmatic trials, external controls, or adaptive studies.
Our experienced team of scientists work with our data and AI technologies to accelerate trial data analysis and to help you implement novel data and analytics techniques for RCTs, pragmatic trials, external controls, or adaptive studies.
COMMERCIAL SOLUTIONS

Drive Better
Patient Outcomes
for Diseases

Learn More
  • AML
  • Breast Cancer
  • Cirrhosis
  • Fabry Disease
  • GIST
  • Hemophilia
  • Hepatitis C
  • Leukemia
  • Multiple Sclerosis
  • Myelofibrosis
  • Plaque Psoriasis
  • Prostate Cancer
  • Pulmonary Arterial Hypertension
  • Rheumatoid Arthritis
  • Schizophrenia
  • Tardive Dyskinesia

Innovate with ConcertAI – We’re hiring!

Join the fastest growing AI-powered SaaS and data company in healthcare. We are looking for motivated, curious, independent people dedicated to transforming how healthcare is delivered. Talk to us about how to make an impact.